Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
30
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Samsung Electronics
AN
AnalystConsensusTarget
Consensus Narrative from 34 Analysts
AI And Memory Demand Will Catalyze Semiconductor Turnaround
Key Takeaways Leadership in advanced semiconductor technologies and high-performance memory is driving customer wins, higher margins, and expanding Samsung's presence in new and existing markets. Diversification into premium products, AI-powered devices, and high-margin sectors is supporting resilient profitability and reducing revenue cyclicality.
View narrative
₩82.69k
FV
13.7% undervalued
intrinsic discount
4.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
67
users have followed this narrative
4 days ago
author updated this narrative
Novo Nordisk
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
GLP-1 Therapy Penetration And Global Launches Will Unlock Market Potential
Key Takeaways Vast global demand for GLP-1 therapies and metabolic disease treatments offers long-term revenue growth, as adoption and access increase amid rising obesity and aging trends. Expanded product launches, manufacturing investments, and innovation in new disease areas are set to boost market reach, support resilient earnings, and reduce supply constraints.
View narrative
DKK 484.33
FV
24.9% undervalued
intrinsic discount
8.34%
Revenue growth p.a.
Set Fair Value
10
users have liked this narrative
3
users have commented on this narrative
436
users have followed this narrative
4 days ago
author updated this narrative
Tencent Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 46 Analysts
AI And WeChat Expansion Will Fuel Long-term Growth
Key Takeaways AI integration and WeChat ecosystem expansion are driving efficiency, deeper user engagement, and improved monetization across Tencent's core business areas. Growth in cloud, fintech, and international gaming is boosting higher-margin revenues and diversifying earnings for long-term business sustainability.
View narrative
HK$682.23
FV
12.1% undervalued
intrinsic discount
10.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
100
users have followed this narrative
4 days ago
author updated this narrative
SuperCom
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Government Contracts And AI Analytics Will Expand Markets Despite Risks
Key Takeaways Expansion into government electronic monitoring, digital innovation, and new U.S. markets positions SuperCom for recurring revenue growth and improved earnings stability. Operational efficiencies, proprietary solutions, and strategic partnerships drive higher margins, greater cash flow visibility, and increasing long-term profitability.
View narrative
US$15.00
FV
38.1% undervalued
intrinsic discount
13.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 days ago
author updated this narrative
Urgent.ly
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Insurance Expansion And AI Efficiency Will Drive Future Value
Key Takeaways Expansion into the insurance sector and long-term partnerships position the company for accelerated B2B revenue growth and recurring high-value contracts. Investments in AI-driven efficiencies and cost reductions enhance customer satisfaction, operating margins, and support the shift toward positive cash flow.
View narrative
US$11.50
FV
59.9% undervalued
intrinsic discount
14.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
X4 Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
US Launch And EMA Approval Will Expand Global Reach
Key Takeaways The transition to a commercial-stage pharmaceutical and strategic international partnerships could significantly boost revenue growth and international market presence. Successful trials and restructuring efforts anticipate improved profitability and financial sustainability while targeting broader patient populations.
View narrative
US$23.25
FV
83.1% undervalued
intrinsic discount
51.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
ONIT
Onity Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Transformation And Proprietary Technology Will Secure Durable Advantages
Key Takeaways Strategic investment in proprietary technology and digital channels is driving operational efficiency, recurring revenue, and long-term asset growth. Above-industry growth, dynamic asset management, and market share gains position the company for superior earnings and resilience in volatile markets.
View narrative
US$53.33
FV
22.2% undervalued
intrinsic discount
9.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Paysign
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Payment Solutions Will Expand Healthcare Access Further
Key Takeaways Strategic diversification and regulatory alignment in healthcare and payments position Paysign to expand margins and strengthen its competitive advantage amid industry consolidation. Growth in digital payment demand, recurring high-margin healthcare programs, and adoption in gig payroll drive robust and resilient future revenue streams.
View narrative
US$9.10
FV
40.7% undervalued
intrinsic discount
21.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
4 days ago
author updated this narrative
Zynex
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Aging Populations And FDA Moves Will Unlock New Markets
Key Takeaways Rising demand for non-opioid pain management and regulatory trends support Zynex's expansion into new markets and product lines. Operational restructuring and leadership changes are positioned to improve margins, cash flow, and drive future earnings growth.
View narrative
US$2.85
FV
41.8% undervalued
intrinsic discount
-5.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies